\nBetween 2025 and 2026, China’s clear aligner market is accelerating through a dramatic shakeout. The overall market continues to grow \u2014 reaching approximately RMB 5.4 billion (USD 750 million) in 2024, up 15% year-over-year \u2014 yet the number of viable players is shrinking, with concentration tilting further toward the top two incumbents.
\nKlick Aligner: The Fall of the “Third Place”<\/strong>
\nOn December 9, 2025, Klick Aligner \u2014 widely regarded as China’s third-ranked domestic clear aligner brand \u2014 issued a service suspension announcement. The ten-year-old company had built a network covering 1,800 cities, 50,000+ dental clinics, and 80,000 registered dentists. Its collapse was multi-causal: centralized procurement policies in 2024 undercut its price advantage in lower-tier markets; cumulative R&D exceeding RMB 400 million failed to build durable moats; and a dispersed 13-shareholder ownership structure meant critical strategic pivots were never executed in time.
\nThe fallout was messy. Thousands of active patients faced interrupted treatment. Angelalign and Shuyaqi eventually took over some cases, but the damage to clinic-brand trust was done.
\nHaolijia Dental: Expansion Kills<\/strong>
\nJust months later, Haolijia Dental \u2014 a chain brand focused on early pediatric orthodontic intervention \u2014 abruptly closed locations across four cities. Founder Huang Wei candidly acknowledged the error: blind pursuit of scale, with expansion far outpacing management capacity, drained cash flow until the chain simply broke. The brand had invested heavily in an AI digital system with 170,000 pediatric case records \u2014 yet never converted that asset into revenue, a stark reminder that digital capability without clinical delivery quality is a path to nowhere.<\/p>\n
<\/p>\n
Global Resonance: Same Script, Different Cast<\/strong> In the DTC segment, the damage was even more severe. SmileDirectClub filed for Chapter 11 in September 2023 and ceased operations by December, leaving nearly USD 900 million in debt. Its “dentist-bypassing” remote model accumulated massive lawsuits due to treatment failures. Byte (Dentsply Sirona) and Australia’s SmileStyler followed similar paths.<\/p>\n A common logic runs through all of this: in healthcare, brands without core technological substance and clinical delivery capability \u2014 regardless of valuation \u2014 have nowhere to hide when the tide recedes.<\/p>\n <\/p>\n The Real Bottleneck: Design Capacity, Not Production<\/strong> A complete clear aligner delivery chain has four links: clinical data capture, treatment planning design (TPS), manufacturing, and clinical monitoring. Treatment planning is the technical apex. It demands the integration of biomechanical principles, physiological limits of tooth movement, material science, and individual patient conditions into a pre-planned, multi-year safe movement trajectory. Every case is a deep clinical judgment call.<\/p>\n Most emerging brands and DTC companies lack professional in-house design teams, forcing them to outsource TPS to low-cost remote providers. These providers rely on semi-automated AI software capable only of simple alignment cases. When confronted with extraction-based treatment, TAD assistance, vertical control, or bite reconstruction \u2014 moderate to complex cases \u2014 they “force through” with disastrous results.<\/p><\/blockquote>\n This creates a vicious cycle: brands cut costs with cheap TPS \u2192 complex case quality collapses \u2192 complaints and refunds surge \u2192 brand reputation dies \u2192 further cost cuts. Everyone loses, especially the patients.<\/p>\n <\/p>\n The 60-20-20 Rule<\/strong><\/p>\n In clear aligner therapy, outcome effectiveness follows a well-established framework:<\/p>\n The treatment plan is the “source code” of clear aligner therapy. It determines staging, trajectory, and force application. When low-cost TPS teams process moderate and complex cases as assembly-line products, they undermine the 60% foundation. Without deep orthodontic expertise, designers are merely “dragging teeth” on a software interface \u2014 not making medical decisions.<\/p>\n <\/p>\n What Effective Clear Aligner Design Capacity Actually Means<\/strong> When you evaluate a clear aligner design partner, these four pillars are the non-negotiable criteria. A team that checks all four boxes is extraordinarily rare \u2014 and that scarcity is precisely why brands that rely on cut-rate TPS are facing the reckoning we see today.<\/strong><\/p>\n The hard truth: The market is flooded with TPS teams that can handle simple aligner cases using automated tools. But when it comes to moderate and complex clear aligner case design \u2014 the cases that truly differentiate a brand and generate long-term patient loyalty \u2014 the vast majority of low-cost providers are simply not qualified. They lack the clinical expertise, the communication infrastructure, and the quality assurance systems to deliver consistent outcomes. That is the gap BEST SMILE TECH and a handful of specialized OEMs fill.<\/p><\/blockquote>\n The Education Gap and the 70% Opportunity<\/strong> The 70% traditional share is not a sign of clear aligner immaturity \u2014 it signals a massive conversion opportunity. For leading brands like Invisalign and Angelalign, this is the core battlefield. For professional OEMs like BEST SMILE TECH with proven moderate and complex case delivery capability, it is an equally vast blue ocean.<\/p>\n <\/p>\n Building Walls in Chaos<\/strong><\/p>\n The more chaotic the market, the more valuable genuine capability becomes. Companies like BEST SMILE TECH \u2014 with teams of professionally trained orthodontic reviewers, full-spectrum digital orthodontic design capability, and ISO 13485-certified manufacturing \u2014 represent scarce infrastructure in an industry hemorrhaging trust. <\/p>\n The Sky Will Be Clearer After the Storm<\/strong><\/p>\n The clear aligner industry is undergoing a painful but necessary maturation. The fall of Meilikesi, Haolijia, and SmileDirectClub represent the inevitable cost of transitioning from chaotic growth to disciplined operation.<\/p>\n The core truth exposed: clear aligners are medical devices, not consumer goods. They are clinical medicine, not software algorithms. When capital’s tide recedes, those who remain will be the ones who respected medical substance, built design capacity, and safeguarded treatment quality.<\/p>\n For the dental community, accelerating clear aligner education is the key to unlocking the 70% untapped market. For the “wall-builders” who understand what “capacity” truly means \u2014 the storm is not the endgame. It is the starting point of a new era.<\/p>\n The global clear aligner industry is undergoing a painful but necessary maturation, marked by high-profile bankruptcies including SmileDirectClub, Klick Aligner, and Haolijia Dental, alongside massive stock devaluations for incumbents like Align Technology. This article argues that these failures are not isolated market events but the explosive eruption of long-concealed structural contradictions: brands lacking core technological substance and clinical delivery capability cannot survive when capital tides recede. The true bottleneck is not manufacturing capacity\u20143D printers and thermoforming machines can be scaled with capital\u2014but qualified treatment planning design (TPS) capacity. A complete aligner delivery chain comprises clinical data capture, treatment planning design, manufacturing, and clinical monitoring; treatment planning is the technical apex, demanding integration of biomechanical principles, physiological limits, material science, and individual patient conditions. The article introduces the “60-20-20” effectiveness framework, where treatment plan design accounts for 60% of clinical outcomes, and defines four pillars of effective design capacity: professional orthodontic design teams, deep case experience across complexity levels, cloud-based case delivery and production integration, and direct clinical communication with design rationale. It further highlights the 70% global share of traditional fixed orthodontics as a massive conversion opportunity for brands and OEMs with proven moderate and complex case delivery capability. Ultimately, clear aligners are medical devices, not consumer goods; those who invest in medical substance and design capacity will define the next decade.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-global-header-display":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"categories":[770,1],"tags":[599,167,600,186,601,189,191,195,408,514,586,592,593,594,595,596,597,598],"class_list":["post-1753","post","type-post","status-publish","format-standard","hentry","category-ai-aligner-design-software","category-blog","tag-aligner-manufacturing","tag-digital-orthodontics","tag-aligner-biomechanics","tag-clear-aligner-industry","tag-iso-13485-aligner","tag-clear-aligner-design-capacity","tag-clear-aligner-oem","tag-smiledirectclub-bankruptcy","tag-orthodontic-industry-trends","tag-60-20-20-rule","tag-complex-aligner-cases","tag-aligner-market-shakeout","tag-clear-aligner-bankruptcy","tag-klick-aligner","tag-align-technology-stock","tag-treatment-planning-design","tag-aligner-tps","tag-clear-aligner-education"],"_links":{"self":[{"href":"https:\/\/www.bestsmiletech.com\/es\/wp-json\/wp\/v2\/posts\/1753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bestsmiletech.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bestsmiletech.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bestsmiletech.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bestsmiletech.com\/es\/wp-json\/wp\/v2\/comments?post=1753"}],"version-history":[{"count":3,"href":"https:\/\/www.bestsmiletech.com\/es\/wp-json\/wp\/v2\/posts\/1753\/revisions"}],"predecessor-version":[{"id":2079,"href":"https:\/\/www.bestsmiletech.com\/es\/wp-json\/wp\/v2\/posts\/1753\/revisions\/2079"}],"wp:attachment":[{"href":"https:\/\/www.bestsmiletech.com\/es\/wp-json\/wp\/v2\/media?parent=1753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bestsmiletech.com\/es\/wp-json\/wp\/v2\/categories?post=1753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bestsmiletech.com\/es\/wp-json\/wp\/v2\/tags?post=1753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nChina’s turbulence was not isolated. In Q2 2025, Align Technology’s stock crashed 37% in a single day; its market cap had evaporated over USD 40 billion from its 2021 peak. Invisalign’s global share dropped from a dominant 80%+ to below 60%.<\/p>\n
\nHere is the inconvenient truth the industry has long ignored: the true bottleneck is not aligner manufacturing \u2014 it is treatment planning design capacity. 3D printers and thermoforming machines can be scaled with capital. Qualified treatment planners cannot.<\/p>\n![\"\"](\"https:\/\/www.bestsmiletech.com\/wp-content\/uploads\/2026\/05\/ScreenShot_2026-05-31_081414_756.webp\")
<\/p>\n
\nThe industry talks about “capacity” as if it were a single dimension \u2014 number of designers, cases per day, output volume. This is dangerously wrong. True effective clear aligner design capacity is a multidimensional capability that most emerging brands and low-cost TPS providers simply do not possess. Here is what it actually looks like:
\n1<\/strong>
\nProfessional Orthodontic Design Teams<\/strong>
\nNot generic dental technicians or software operators, but specialists trained in clear aligner biomechanics, attachment design, and staging optimization. Every treatment plan must pass review by clinicians who understand why teeth move \u2014 not just how to drag them in software.
\n2<\/strong>
\nDeep Case Experience Across Complexity Levels<\/strong>
\nA capable provider must go far beyond simple crowding or spacing cases. Effective capacity means proven competency in moderate and complex case design \u2014 extraction-based treatment, deep bite and open bite correction, crossbite resolution, TAD-assisted anchorage, skeletal discrepancies, and full-mouth reconstruction with inter-arch coordination.
\n3<\/strong>
\nCloud-Based Case Delivery & Production Integration<\/strong>
\nEffective capacity is not just about designing good plans \u2014 it is about delivering them efficiently. A robust cloud platform enables seamless case submission, design iteration, dentist feedback loops, and direct production handoff. This eliminates the friction that plagues email-based, disconnected workflows where files get lost and revisions take days.
\n4<\/strong>
\nDirect Clinical Communication & Design Rationale<\/strong>
\nThis is where most TPS providers fail entirely. An effective design partner does not just deliver a treatment plan file \u2014 they explain it. They communicate the rationale behind extraction decisions, staging sequences, attachment choices, and potential refinement triggers. They engage in back-and-forth clinical dialogue with the treating dentist, not one-way file dumps. This consultative capability is what separates a design vendor from a true clinical partner.<\/p>\n
\nBehind the design capacity crisis lies a deeper structural issue: dental education globally is still overwhelmingly rooted in traditional fixed orthodontics. Clear aligner education, as a systematic discipline, only emerged in the past decade. The result? Two critical consequences:<\/p>\n![\"\"](\"https:\/\/www.bestsmiletech.com\/wp-content\/uploads\/2026\/05\/ScreenShot_2026-05-31_081854_655.webp\")
<\/p>\n
\nGlobal design capacity capable of reliably delivering moderate and complex cases is extremely scarce. It cannot be solved by adding 3D printers. It requires years of accumulated clinical knowledge, design experience, and quality control. Those who persistently invest in medical substance and design capacity will define the next decade.<\/p>\n![\"\"](\"https:\/\/www.bestsmiletech.com\/wp-content\/uploads\/2026\/05\/\u5fae\u4fe1\u56fe\u7247_20260530115620_8116_4.webp\")
<\/p>","protected":false},"excerpt":{"rendered":"